Humanigen Inc (fka HGENQ)

[Knuckle Sandwich]

HGEN could definitely fit into the later part of his response as they are on the cusp of Major news. Not only will 2021 provide EUA & BLA for Lenzilumab, but they will see data in Car-T and Glioblastoma with Ifabotuzumab. They will also kick off Trials in GVHD and a Phase II in CMML following thier 2020 completion in Phase I. Future looks very bright here, and how they choose to navigate the next quarter will be very interesting to watch. I am excited for either possibility happening here. A buyout is great. A resistance to buyout is potentially explosive. I have always been of the mindset that Buyout is inevitable especially with the Gilead ties. Let's roll!